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Abstract
A disintegrin and metalloproteinases (ADAMs) constitute a protein family essential for extra-
cellular signaling and regulation of cell adhesion. Catalytic activity of ADAMs and their pre-
dicted potential for Src-homology 3 (SH3) domain binding show a strong correlation. Here we
present a comprehensive characterization of SH3 binding capacity and preferences of the
catalytically active ADAMs 8, 9, 10, 12, 15, 17, and 19. Our results revealed several novel
interactions, and also confirmed many previously reported ones. Many of the identified SH3
interaction partners were shared by several ADAMs, whereas some were ADAM-specific.
Most of the ADAM-interacting SH3 proteins were adapter proteins or kinases, typically asso-
ciated with sorting and endocytosis. Novel SH3 interactions revealed in this study include
TOCA1 and CIP4 as preferred partners of ADAM8, and RIMBP1 as a partner of ADAM19.
Our results suggest that common as well as distinct mechanisms are involved in regulation
and execution of ADAM signaling, and provide a useful framework for addressing the path-
ways that connect ADAMs to normal and aberrant cell behavior.
Introduction
ADAM-mediated protein ectodomain cleavage—dubbed shedding—provides means to rapidly
modify the amount and function of proteins on the cell surface. ADAM substrates range from
growth factors and cytokines to receptors and adhesion proteins. Their cleavage regulates or
initiates many cellular processes including cytokine and growth factor signaling, cell adhesion,
cell migration, and release of intracellular signaling domains from membrane bound precursor
proteins. Shedding is thus a central regulatory mechanism of several major signaling pathways
involved in cell proliferation, polarization, adhesion, and migration (reviewed in [1,2]).
ADAM17 with over a hundred identified substrates, and ADAM10 with seventy, are the pri-
mary sheddases responsible for most of the ADAM-mediated ectodomain shedding character-
ized so far [1]. Although they share more than half of the substrates, usually shedding by
ADAM10 or ADAM17 is initiated by different stimuli [3,4]. In many cases ADAM10 is either
constantly shedding or activated by Ca2+ influx, whereas ADAM17 can be activated with
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stimulation of various signaling pathways, including PKC, MAPK, and PDK1, and in some
cases involving ADAM17 cytosolic tail phosphorylation. Recently, ADAM17 substrate selectiv-
ity was shown to depend on activation of distinct PKC isoforms [5–7]. However, the regulation
of activation and substrate selectivity of ADAMs 10 and 17 is still poorly understood [8].
Other ADAMmetalloproteases with reported cellular substrates are ADAMs 8, 9, 12, 15,
19, and 28 [1]. Compared to the ADAM10 and ADAM17, they have more restricted substrate
repertoires, and can be called secondary sheddases. However, dysregulation of these ADAMs
can seriously affect normal cellular physiology. They all are associated with immune and in-
flammatory disorders [9,10], different types of cancers [11–13], and thus represent attractive
candidates for development of therapeutics. For example, silencing of ADAM9 prevents tumor
invasiveness in vitro and blocks cancer metastasis in vivo [14,15].
Compared to ADAM10 and ADAM17, even less is known about the regulation of sheddase
activity of the secondary sheddase ADAMs. Different PKC isoforms have been associated with
ADAM9 and ADAM12 regulation [16,17], and in some cells stimulation of G-protein coupled
receptors induce EGF-like growth factor shedding mediated by ADAM12 or ADAM15 [18,19].
SH3 domains of Eve-1 and Pacsin3 interact with many ADAMs and can regulate at least hb-
EGF shedding by ADAM12 [20,21], suggesting that intracellular SH3 domain interactions reg-
ulate ectodomain activity of the ADAMs. Interestingly, alternative splicing can profoundly
modulate the number and composition of SH3 binding motifs in the ADAM15 cytosolic tail
[22–24], and the presence of an alternatively used Src SH3 target motif can increase the capaci-
ty of ADAM15 to stimulate fibroblast growth factor receptor-2 shedding [25]. ADAM15 shows
aberrant isoform expression in breast cancer and the presence of certain isoforms correlate
with poorer relapse free survival [26,27].
Src homology 3 (SH3) domains are small protein interaction modules that recognize pro-
line-rich motifs in their target proteins [28]. They can be found in almost 200 human proteins,
often in multiple copies, whereby they regulate numerous cellular signaling pathways, for ex-
ample via determining the catalytic activity and ligand selectivity of protein kinases [29]. The
multiple SH3 domains and/or SH3 binding sites found in many adapter proteins serve to coor-
dinate the assembly of multi-protein signaling complexes, often related to sorting, endocytosis,
and actin remodeling, which are all highly relevant cellular functions for ADAM regulation
and signaling.
Another important aspect of ADAM tails is their capacity to activate intracellular signaling
pathways, which can also be regulated by SH3 interactions. For example binding of the SH3
domain of Src tyrosine kinases or p85α to ADAM12 activates PI3K signaling [30,31], and ex-
tracellular cross-linking of ADAM12 induces clusters of invadopodia in a Src and SH3 binding
dependent manner [32]. Likewise, SH3-mediated interactions of ADAM15 with Src promote
Src/FAK signaling to render chondrocytes and synovial fibroblasts more resistant to apoptosis
[33,34], and Src/Erk1/2 signaling can regulate endothelial cell monolayer permeability [35].
Our previous studies have established the value of the human SH3 domain phage display li-
brary screening by identifying preferred SH3 partners for known or suspected ligand proteins
[36–39]. We have also used this technology to determine the effects of alternative mRNA splic-
ing on SH3 binding selectivity of ADAM15 [24]. In the current study this approach was used
to comprehensively characterize the SH3 binding capacity and preferences of catalytically ac-
tive ADAMs, which was accomplished by subjecting our human SH3 library for exhaustive
screens using the intracellular domains of ADAMs 8, 9, 10, 12, 15, 17, and 19.
SH3 Binding Potential and Specificity of ADAMs
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Materials and Methods
Cell Lines and Reagents
Human embryonic kidney (HEK) 293T cells were maintained in Dulbecco modified Eagle me-
dium (DMEM) supplemented with 10% fetal calf serum (FCS), L-glutamine, penicillin, and
streptomycin. Transient transfections for ADAM-tail bait productions were done with calcium
phosphate as described in Kleino et al. [24] and for co-immunoprecipitations with Fugene 6 ac-
cording to the manufacturer's instructions (Roche Diagnostics Corporation, Indianapolis, IN).
All chemicals for cell culture, cell lysis, and protein works were from Sigma Aldrich (Sigma-Al-
drich) if not stated otherwise.
Construction of Expression and Phagemid Vectors
Biotinylated ADAM-tail proteins were produced by expressing them as fusion proteins with a
biotinylation target domain (BTD). For ADAM15i6, the cytosolic tail encoding fragment was
subcloned from pGEX-construct used in Kleino et al. 2009 [24] into C-terminal position into
pEBB[BTD-mCherry], a pEBB [40] derivative expressing mCherry-BTD fusion BTD being
1–122 residues of the C-terminal biotin acceptor domain of the 1.3S subunit of Propionibacter-
ium shermanii derived from the PinPoint Xa-1 vector (Promega). The following construct will
express flexible linker SGGDRWSSTGGGR between the mCherry and ADAM15. For produc-
tion of biotinylated ADAM8, -9, -12, -17, and -19 tails vectors expressing EGFP-BTD-ADAM-
tail (eBTD-ADAM-tail) fusion proteins were constructed as follows. For empty vector eBTD
fragment of the above mentioned BTD (amino acids 49–112) was inserted into multiple clon-
ing site of pEGFP-C1 (Invitrogen) producing a SGLRSTGGTM linker between the EGFP and
BTD. The ADAM-tails encoding DNA fragments were subcloned from corresponding pGEX--
ADAM-tail vectors into downstream of BTD producing ERSPEF linker between the BTD and
each ADAM tail. The original pGEX ADAM-tail plasmids were constructed by inserting PCR
amplified DNAs from image clones with accession numbers BC024214 (ADAM19), BQ708311
(ADAM8), and PCR amplified DNAs derived from cDNAS produced from SK-BR3 or Jurkat
RNAs (ADAMs -9, -12, and -17). The ADAM-tails expressed from above mentioned vectors
are exactly as follows: ADAM8: HIIVYRKARSRILSRNVAPKTTMGRSNPLFHQAASRV
PAKGGAPAPSRGPQELVPTTHPGQPARHPASSVALKRPPPAPPVTVSSPPFPVPVYTR
QAPKQVIKPTFAPPVPPVKPGAGAANPGPAEGAVGPKVALKPPIQRKQGAGAPTAP
ADAM9: RDQLWRSYFRKKRSQTYESDGKNQANPSRQPGSVPRHVSPVTPPREVPIYANR
FAVPTYAAKQPQQFPSRPPPPQPKVSSQGNLIPARPAPAPPLYSSLT ADAM10:
QICSVHTPSSNPKLPPPKPLPGTLKRRRPPQPIQQPQRQRPRESYQMGHMRR ADAM12:
RKTLIRLLFTNKKTTIEKLRCVRPSRPPRGFQPCQAHLGHLGKGLMRKPPDS YPPKDNP
RRLLQCQNVDISRPLNGLNVPQPQSTQRVLPPLHRAPRAPSVPARPLPAKPALRQAQGT
CKPNPPQKPLPADPLARTTRLTHALARTPGQWETGLRLAPLRPAPQYPHQVPRSTHT
AYIK ADAM15: MLGASYWYRARLHQRLCQLKGPTCQYRAA QSGPSERPGPPQRAL
LARGTKQASALSFPAPPSRPLPPDPVSKRLQAELADRPNPPTRPLPADPVVRSPKSQG
PAKPPPPRKPLPADPQGRCPSGDLPGPGAGIPPLVVPSRPAPPPPTVSSLYL ADAM17:
HSILVHCVDKKLDKQYESLSLFHPSNVEMLSSMDSASVR IIKPFPAPQTPGRLQPAPVIP
SAPAAPKLDHQRMDTIQEDPSTDSHMDEDGFEKDPFPNSSTAAKSFEDLTDHPVTRSE
KAASFKLQRQNRGDSKETEC
GST-SH3 expression vectors were prepared by subcloning SH3 domain sequences from
SH3 phagemids described in [24,36] into pGEX-4T-1. Tagged ADAM8, SNX33, and TOCA1
used in co-immunoprecipitations were constructed as follows. Full length ADAM8 from plas-
mid IMAGE ID: 5324943 was PCR-amplified and inserted in-frame into pEBB derivative
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containing C-terminal HA-tag. EGFP-SNX33 expression vector was produced by PCR ampli-
fying SNX33 fragment from pEBB-BTD-SNX33 [24] and by inserting it into pEGFP-C1 (Clon-
tech). pEGFP-TOCA1 vector was a gift from Pietro De Camilli.
Protein Production
Phage screen target-proteins were expressed in and purified from HEK293T cells as follows.
3.5 x 106 HEK293T cells in a 6-well plate were transfected with expression vector for ADAM-
tail or control protein. The transfection efficiency was monitored by determining the EGFP or
mCherry distribution and levels with inverted fluorescence microscope (Olympus). 36 h post
transfection the cells were collected into ice cold PBG-buffer [PBS solution with 10% glycerol]
supplemented with Complete protease inhibitor cocktail (Roche). Cell lysis and release of pro-
teins was accomplished by sonication of the cell suspension for 7 cycles of 4 seconds on/3 sec-
onds off with 40% amplitude in Sonopuls HD 3200 sonicator (Bandelin). Lysates were cleared
by centrifugation at 12.000 x g for 30 min and stored in -20°C. GST-SH3 proteins used in prob-
ing of CelluSpot peptide arrays were produced in pGEX-SH3 transformed BL21 E.coli and pu-
rified with glutathione 4B beads according to standard batch purification protocol in
manufacturers manual (GE Healthcare).
Phage Libraries and Screening
For the 117 independent phage screens done in this work, 34 custom SH3 phage libraries (S1
Table) were prepared fromM13 derived phagemid vectors described in [36] by using methods
described in [36,41]. To avoid library based bias, at least two independently prepared libraries
with the same SH3-domain compositions were prepared and screened at each selection stage.
Fresh phage libraries were filtered with 0.22 μm filter and stored at +4°C and used within 4
weeks from the preparation. We have not observed any weakening in library performance dur-
ing that time. If strong ADAM-binders were identified from the library, a new reduced library
lacking the identified SH3-domain phages were prepared. Differing from the original full SH3
phage library [36], all libraries used in this study lacked SH3 phages of Crk(II) and CrkL(II) as
we have previously observed these atypical SH3 domains to be prone for selection without true
affinity to diverse targets and hence causing false positives.
SH3 phage screening was done essentially as in [24,36] except that instead of a plastic sur-
face, the target proteins were immobilized onto streptavidin magnetic beads. The following de-
scribes the differences to previous protocols [24,36]. HEK293T cell lysates containing biotin
ADAM-tail proteins were transferred on 7 μl of M-280 streptavidin Dynabead suspension
(Invitrogen) in 1.5 ml Eppendorf tubes. Streptavidin beads were allowed to attach the biotiny-
lated proteins in the lysates in room temperature (RT) in slow rotation for 1 h followed by 4
washes with 1.5 ml of the PBG. Finally the beads with captured target proteins were resus-
pended into 50 μl of PBST (PBS + 0.05% Tween 20). For each screen 400 μl of the phage library
was blocked with 400 μl of 4% milk in PBST and then added on the target protein-beads and
incubated for 2 h in rotation in RT. After capture, the beads were washed four times with
PBST. To prevent tube carried contamination the bead-target mix was transferred into fresh
tube between the third and fourth washes. After final wash the bait-phage mix was suspended
into 100 μl of sterile LB medium, and 50 μl of this was used to infect E.coli as described in [36].
The identity of the SH3 domains of the selected phages was determined as described in [24].
EGFP, mCherry, BTD, or endogenous bead bound material from 293T captured with M-280
beads was found negative in selecting SH3 domain phages as indicated by small number of re-
tained phages and unbiased set of phages identified amongst retained ones (79 different SH3s
out of 119 phages).
SH3 Binding Potential and Specificity of ADAMs
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CelluSpot Peptide Arrays Probing
Synthesis and probing of CelluSpot arrays were done essentially as described in [24]. In current
study, each peptide array slide contained three separate sub-arrays of peptides. To prevent
oversaturation and to see differences better with weaker binders different concentrations of
GST-SH3 domains were used to probe the slides as follows: 20 μg/ml, Hck, Eps8L1, Nck(I),
SNX9, TOCA1, RIMBP1(III); 15 μg/ml, Tec, RIMBP2(III), RIMBP3(III), formin binding pro-
tein 17 (FBP17), 10 μg/ml Tks5(I), Tks5(V), intersectin1(III), intersectin2(III), SNX18, Lyn,
Fyn, Itk, Btk, Lck, CIP4, NCF1(I), Grb2(II), AHI1, OSTF1; 5 μg/ml SNX33, Src, Grb2(I),
nephrocystin, and 2 μg/ml p85α. These concentrations were empirically chosen to maximally
differentiate the peptide binding signal intensities, and to achieve an optimal signal to noise
ratio for each SH3 domain probe.
The bound GST-SH3 domains were detected with IRDYE-680 labeled anti-GST (Li-cor Bio-
sciences) at 1:5000 dilution and the signals from probed slides were scanned in Li-cor Odyssey
Near Infrared imaging system (Li-cor Biosciences). Individual spot signals from slide images
were quantified by Odyssey software (Li-cor Biosciences). Each ADAM-peptide-SH3 signal
was averaged from three spots, which were first subtracted with slide specific background. Av-
erage signal from 33 empty spots increased with 2x standard deviations of empty spots was
used as background. To exclude non-specific binding of GST or anti-GST-antibodies to pep-
tides the slides were also probed with varying concentrations GST-only and signals from those
were compared to patterns from ADAM-binding SH3 domains. Each SH3-domain probing
was normalized to strongest signal showing in each column as 2. Data was analyzed with Clus-
ter 3 software (Eisen, eisen@rana.lbl.cov and de Hoon, mdehoon@gsc.riken.jp, http://bonsai.
hgc.jp/~mdehoon/software/cluster/). The peptidearray image was produced in Java TreeView
(Alok, alokito@users.sourceforge.net, http://jtreeview.sourceforge.net).
Antibodies, Western Blotting and Immunoprecipitation
Mouse monoclonal antibody recognizing the HA-epitope (F-7) and rabbit polyclonal antibody
to GFP (sc-8334) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The
mouse monoclonal antibody to α-tubulin (T6199) was from Sigma-Aldrich Corp. (St. Louis,
MO). When Western blotting tissue culture cells were lysed in KEB lysis buffer [137 mMNaCl,
50 mM Tris/HCl [pH 8], 2 mM EDTA, 0.5% Nonidet P-40, and protease inhibitors]. Fifty mi-
crograms of total proteins were analyzed by 8% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and blotted according to standard protocols.
For detection of association between ADAM8 and SNX33 or TOCA-1, HEK293T cells were
transfected with ADAM8-HA, EGFP-TOCA-1, and EGFP-SNX33 expression vectors, lysed
with the KEB lysis buffer. Cleared cell extracts (600 μg) were incubated with anti-HA mouse
monoclonal antibody for 2 hours at +4°C. Immunocomplexes were coupled to protein G
Sepharose beads (Dynabeads Protein G, Invitrogen, San Diego, CA) for additional 2 hours at
4°C and washed 3 times with the lysis buffer. The immunoprecipitates were boiled in Laemmli
sample buffer and subjected to SDS-PAGE andWestern blotting analysis.
Results
Phage library profiling of SH3 binding capacity and selectivity of ADAM
tails
To identify human ADAMs with SH3 binding potential we first examined their cytosolic do-
mains for the presence of canonical SH3 target motifs or other proline-rich sequences sugges-
tive of SH3 binding (see [28]). With the exception of ADAM28 and ADAM33 one or more
SH3 Binding Potential and Specificity of ADAMs
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candidate SH3-binding sites were evident in all of the 9 ADAMs with established catalytic ac-
tivity (Fig 1A and 1B). By contrast, with the exception of ADAM22, no potential SH3 target
sites could be identified in the 11 other ADAMs.
The intracellular domains of ADAMs 8, 9, 10, 12, 15, 17, and 19 were used as affinity ligands
for screening of our human SH3 domain phage-display library. These ADAM tails were ex-
pressed in human 293T cells as fusion proteins (Fig 1C) containing a biotinylation target do-
main (BTD) and a fluorescent domain (Materials and methods), and captured on
paramagnetic streptavidin-coated beads for phage library panning. The overall success of this
strategy was found superior compared to plastic well passively coated with ADAM-tails ex-
pressed as GST fusion proteins in E. coli (data not shown).
All ADAM-tails were used at least twice to screen independently prepared versions of the
complete SH3 phage library. To better identify also the SH3 domains binding these ADAMs
with a lower affinity additional libraries were sequentially constructed and screened as outlined
in Fig 2 and detailed in S1 Table. SH3 phages that dominated among the clones selected by
ADAMs 8, 9, 12, 15, and 19 in the prior selection experiment were excluded from these cus-
tomized “reduction libraries” used for further affinity panning.
The overall enrichment of phages from the complete SH3 library (i.e. apparent SH3 binding
capacity) varied greatly between the different ADAMs. As shown in Table 1, ADAMs 8, 9 and
15 supported robust SH3 phage enrichment, ADAMs 12, and 19 also showed strong albeit less
Fig 1. Cytosolic tails of ADAM-metalloproteases and their candidate SH3 binding motifs. A. Schematic
presentation of ADAM cytosolic tails with the location of the candidate SH3-binding proline clusters indicated
by circles with roman numerals counting from the transmembrane region to the carboxy terminus. The scale
bar indicates distance in amino acid residues.B. Potential SH3 binding sequences within the proline clusters
shown in A. Established SH3 target motifs (+ΦPxxP, PxΦPx+, PxxDY, where + is K or R andΦ is a
hydrophobic residue) occurring individually or in clusters where they partly overlap each other are indicated in
bold. C.Western blotting analysis of the ADAM tails expressed as biotinylated fusion proteins in human 293T
cells for use as affinity baits in SH3 domain library screening.
doi:10.1371/journal.pone.0121301.g001
SH3 Binding Potential and Specificity of ADAMs
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intense SH3 phage binding capacity, whereas phage enrichment by ADAMs 10 and 17 was
modest.
Accordingly, sequencing of a large number (n = 237) of phage clones obtained from pan-
ning with ADAM10 or ADAM17 indicated no obvious selectivity towards any SH3 domain.
By contrast, enrichment of phages by ADAMs 8, 9, 12, 15, and 19 was in all cases also associat-
ed with an apparent SH3 binding selectivity. The two SH3 domains most frequently selected
from the complete SH3 library represented 94% of all sequenced phage clones for ADAM9 as
well as for ADAM15, 80% for ADAM19, 72% for ADAM8, and 47% for ADAM12. The identi-
ties of these dominant SH3 domains differed between the ADAMs, although sorting nexin 33
(SNX33) was found to be the preferred partner for three different ADAMs (ADAM8, ADAM
9, and ADAM15).
Further screening of reduction libraries customized for each ADAM led to identification of
4 to 9 highly selected SH3 domains for each of these ADAMs. These SH3 domains are classified
as “dominant” or “strongly selected” in Table 2, which also lists SH3 domains that were mod-
estly but reproducibly selected (classified as “significantly selected”).
As discussed later, the ADAM-targeted SH3 domains were most often found in proteins in-
volved in membrane trafficking, and included some previously known ADAM partners (see
Table 2) as well as novel interactions such as binding of ADAM8 to transducer of Cdc42-de-
pendent actin assembly-1 (TOCA1) SH3 and binding of ADAM19 to RIMBP1(III) SH3. For
proteins containing multiple SH3 domains, the Roman number in parentheses indicates the
SH3 domain in question (counting from the N-terminus).
Mapping of SH3 target motifs by peptide arrays
Some, but not all, of the SH3 binding specificity and affinity determinants can be defined by
short and linear peptide motifs. In order to map the SH3 target motifs within the intracellular
tails of ADAM 8, 9, 10, 12, 15, 17, and 19, as well as to examine the overall correlation between
our phage-library data and binding of the selected SH3 domains to defined proline-rich motifs
in these ADAMs, a peptide array was designed (Fig 3).
Peptides ranging from 14 to 17 amino acids in length corresponding to the putative SH3 tar-
get sites were synthesized and spotted on slides. The slides were probed with 30 different SH3
Fig 2. Outline of phage library screening. A sequential strategy was used for screening of complete as well
as subsequent rationally customized SH3 display libraries in order to exhaustively assess potential SH3
partners of the indicated ADAMs.
doi:10.1371/journal.pone.0121301.g002
SH3 Binding Potential and Specificity of ADAMs
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domains expressed as recombinant GST fusion proteins and the binding was detected with a
fluorescent anti-GST antibody. These SH3 domains were chosen to cover as many as possible
of the interactions identified by phage display (when a soluble SH3 probe could be expressed),
but also included some related SH3 domains (such as Src family members), as well as SH3 do-
mains not identified in our screen but described in the literature as ADAM partners.
The results are summarized as a heat map in Fig 3, showing relative binding of each SH3 do-
main to the test set of 36 ADAM peptides. As apparent from Fig 3, distinct specificities could
be observed, and all SH3 domains showed unique peptide array binding profiles. As expected,
the binding profiles of related SH3 domains, such as members of the Src-family kinases (SFK)
were more similar to each other than—for example—to SNXs. On the other hand, a preference
for canonical motifs typical for SFK was shared by many SH3 domains, such as nephrocystin,
AHI1, OSTF1, intersectin1(III), and Grb2(II).
All SH3 domains classified in Table 2 as dominant or strongly selected ADAM partners
were among the strongest (top six) binders for at least one peptide from the ADAM protein
that selected them from the phage library. On the other hand, certain ADAM-peptides, like
Table 1. Key statistics of phage library selection experiments.
A8 A9 A10 A12 A15 A17 A19
Phage enrichment in the ﬁrst round of library screening 3000 >10,000 50 200 10,000 5 500
Number of customized reduction libraries prepared and screened 5 4 0 3 6 0 4
Total number of SH3 clones identiﬁed by sequencing 332 142 190 384 172 47 203
Total number of selected SH3 domains 8 7 0 8 14 0 14
doi:10.1371/journal.pone.0121301.t001
Table 2. SH3 domain clones selected by intracellular tails of different ADAMs.
ADAM8 ADAM9 ADAM12 ADAM15 ADAM19
Dominant SNX33 SNX33 Src* SNX33* Tks5(I)
TOCA1 SNX9* Nephrocystin
Strongly selected CIP4 Tec Lyn* Tks5(V)* Src
SNX9 SNX18 Tks5(V)* Src* RIMBP1(III)
Tec Hck* SNX9* Eps8L1
Src AHI1 Nephrocystin* NCF1(I)
Hck*
Tec
Lyn*
Tks5(I)*
Signiﬁcantly enriched NCF1(I) NCF1(I) SNX33 p85α* Tec
OSTF1 Lyn SNX9 Btk Lyn
ArgBP2(II) NCF1(I)* p85α
OSTF1 Nephrocystin
intersectin1(III) SNX33
TOCA1
SNX9*
Tks5(V)*
Hck
SH3 domains repeatedly enriched by afﬁnity screening from the complete and subsequently constructed ADAM-speciﬁc reduction libraries. SH3
interactions reported previously are indicated with an asterisk.
doi:10.1371/journal.pone.0121301.t002
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A12-IIIb and A15-II, bound robustly to the majority of the tested SH3 domains, including
many that were not selected by ADAM12 or ADAM15 from the phage library.
Despite a general correlation between these two data sets it was also clear that the binding
preferences of the complete ADAM tails revealed by the SH3 library screening could not be
predicted by the peptide array data. Nevertheless, in most cases the peptide array was informa-
tive in identifying the peptide region serving as the key docking site for each ADAM-binding
SH3 domain.
The number of binding sites and their contribution to SH3 binding varied between the
ADAMs. For example, a single (out of the six predicted) SH3 target site in ADAM12
(A12-IIIb) accounted for all of the strongest interactions by the eight ADAM12-selected SH3
domains. By contrast, four out of five different target sites in ADAM15 bound with distinct
specificities to the panel of SH3 domains selected by ADAM15. On the other hand, two of the
four target motifs in ADAM9 (A9-IIIb and A9-IV) bound with similar strength but high speci-
ficity to SH3 domain partners of ADAM9, namely Tec and SNXs.
Fig 3. Summary of the peptide array data for identification of functional SH3 binding sites in the
ADAM tails. The indicated peptides corresponding to the proline-cluster numbering in Fig 1A were printed in
triplicate on arrays slides, and probed with the indicated SH3 domains. Signals of the triplicate spots were
averaged, and these values normalized to the average of the peptide giving the strongest signal in each SH3
probing. Shown is a heat map based on these normalized values where white indicates background level
binding, and black the strongest peptide binding for each SH3 domain.
doi:10.1371/journal.pone.0121301.g003
SH3 Binding Potential and Specificity of ADAMs
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Most of the ADAM peptides that showed strong SH3 binding contained canonical class I
SH3 binding motifs. Notable exceptions were the class II binding site in ADAM8 (A8-IV) that
bound strongly to multiple SH3 domains, and the two overlapping peptides of ADAM19
(A19-IVc and A19-V) that did not contain a known consensus motif, but bound tightly to the
third SH3 domains of RIMBP1 and RIMP2.
ADAM8 interacts with TOCA1 and SNX33 in transfected human cells
The preferred SH3 partners for ADAM8 found in our screens were TOCA1 and SNX33. More-
over, when these two were excluded from the phage library ADAM8 preferentially selected the
SH3 domains of Cdc42 interacting protein 4 (CIP4) and SNX9, which are the closest relatives
of TOCA1 and SNX33. TOCA1 and CIP4 were specifically selected only by ADAM8, and have
not been previously reported to interact with any ADAM. On the other hand, SNXs were
found to be preferred SH3 partners of many ADAMs, and have already are been reported to in-
teract with ADAMs 9, and 15. However, ADAM8 has not been previously implicated as an
SNX-ligand.
To extend our in vitro binding results, we decided to study interactions of ADAM8 with
TOCA1 and SNX33 using full-length native proteins expressed in human cells. Expression vec-
tors for epitope- or GFP-tagged version of ADAM8, TOCA1, and SNX33 were co-transfected
into HEK 293T cells, and their interactions studied by co-immunoprecipitation. As shown in
Fig 4, TOCA1 and SNX33 could be readily detected from anti-HA immunocomplexes from
Fig 4. ADAM8 interacts with TOCA1 and SNX33 in human cells. SNX33 and TOCA1 were expressed as
EGFP-fusion proteins by transiently transfected 293T cells alone or with HA-tagged ADAM8 as indicated on
top of the figure. The presence of ADAM8 itself (top panel) or TOCA1 or SNX33 that was associated with it
(second panel from top) in anti-HA immunoprecipitates (IP) from the lysates of these cells was examined by
Western blotting. Similar total levels of ADAM8, TOCA1, and SNX33 between the transfected cells were
confirmed by aWestern blotting analysis of the unselected lysates (Lysate). Blotting for the endogenous α-
tubulin in these lysates was included as an additional loading control.
doi:10.1371/journal.pone.0121301.g004
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lysates of ADAM8-HA transfected cells, but not from control cell lysates expressing TOCA1
and SNX33 only.
Discussion
ADAMs are attractive targets for therapeutic intervention in many pathological conditions, in-
cluding various types of cancer [11–13]. Presence of putative SH3 domain binding motifs is a
prominent feature of the cytosolic tails of ADAMs with catalytic activity. In this study we used
a comprehensive human SH3 domain phage display library in combination with peptide array
technology to systematically characterize the SH3 binding capacity and preferences of ADAMs
8, 9, 10, 12, 15, 17, and 19.
The peptide array results helped to characterize the core binding motifs in the ADAMs for
their preferred SH3 domain partners, and showed a general correlation with the phage display
data regarding the SH3 partnering specificity of the ADAMs. However, the peptide data could
not be used to predict the SH3 interactions of the complete ADAM tails revealed by the phage
library screening. Thus, binding determinants beyond individual the proline-rich motifs clearly
provide an important contribution to the SH3 domain selectivity of the ADAM tails. Such de-
terminants could include contacts with regions in the cognate SH3 domain outside of its pro-
line-rich peptide binding groove, or residues that can influence the conformation of the
proline-rich motifs to increase their SH3 binding affinity and specificity.
Several reports have established that the cytosolic tails of ADAM9, 12, 15, and 19 bind a
number of different SH3 domains (see review by [1]). Thirteen of the 24 highly preferred SH3
domain interactions that we identified have been described in previous studies, demonstrating
the power of our approach. Many of the 13 “re-discovered” ADAM interactions involve the
SH3 domains of Tks5 or a member of the SFK or SNX protein families, which we found to be
highly redundant partners of ADAMs considered as the secondary sheddases especially (i.e.
proteolytically active ADAMs other than ADAM10 and ADAM17).
Despite the apparent in vitro promiscuity in binding of SFK/Tks SH3 domains by ADAMs,
these interactions are involved in guiding of complex and highly regulated cellular processes, as
exemplified by the role of ADAM15 in Src/Erk1/2 signaling in endothelial cells [35], Src/FAK
in chondrocytes [34], and ADAM12 signaling via Src/Tks5 in migrating cells [32,42].
Tks5 is a Src substrate that regulates the formation of podosomes and invadopodia via
ADAM12 [32,43], and serves as a regulatory component of the reactive oxygen species (ROS)
producing NADPH oxidase (NOX) complex [44]. Interestingly, we found that ADAMs differ
in their strategies to interact with Tks5 via its multiple SH3 domains. ADAM12 and ADAM15
both bind strongly to Tks5(V), whereas ADAM15 also binds to Tks5(I), which is the principal
SH3 target of ADAM8 and ADAM19.
The ADAMs that bound to Tks5(I) also selected NCF1(I) as one of their preferred SH3 part-
ners. NCF1 (alias p47phox or NOXO2) is a regulatory subunit of phagocyte NAPDH oxidase,
which together with Tks5 belongs to the NAPDH complex organizer superfamily. Indeed, the
N-terminal regions of Tks5 and NCF1 comprise of a PX and two SH3 domains that are very
similar even at the sequence level. Taken together our observations suggest a general role for
ADAMs in spatial coordination of cellular ROS production and its connection to tyrosine
phosphorylation. It is interesting to note that NCF1 protein is using both of its SH3 domains to
sandwich proline-rich ligand peptides between them [45]. It remains to be investigated wheth-
er Tks5 uses a similar double SH3 strategy in binding to ADAMs or peptides from other ligand
proteins.
In addition to the Src-family tyrosine kinases, ADAMs were also found to interact signifi-
cantly with SH3 domains of the Tec-family tyrosine kinases [46], which have previously not
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been identified as ADAM binding partners. Tec was selected by ADAMs 8, 9, 15, and 19, while
ADAM15 also bound Btk. ADAMs 8, 15, and 19 are constitutively expressed or their expres-
sion is induced after stimulation in many hematopoietic lineages, especially in different macro-
phages (see immgen.org for expression profiles). In addition to their roles in lymphocyte
activation, Tec family kinases are also expressed in macrophages and other cells of myeloid ori-
gin [47]. Considering the close functional connections between the Tec and SFK kinase families
in hematopoietic cell signaling [48], it is tempting to speculate that their coordinated interac-
tions with ADAMs might help to regulate the development and function of cells in the immune
system.
Our current results confirm and further emphasize the role of SNX9 and SNX33 as promi-
nent cellular interaction partners of ADAM9 and ADAM15 as previously reported by us and
others [24,36,49]. In addition, we now found that SNX18, the third member of SH3-PX-BAR
subfamily of SNXs [50] is also a preferred binder of ADAM9 and SNX33 is very strong binder
of ADAM8. However, unlike ADAM9 and ADAM15, the cytosolic tail of ADAM8 does not
contain the RxAPxxP sequence, a high affinity binding motif of the SNX9 SH3 domain [51].
Instead, ADAM8 uses two different proline rich SH3 binding sequences for SNX binding.
Members of the SH3-PX-BAR subfamily of SNXs are involved in cellular protein sorting, endo-
cytosis, and dorsal circular ruffle formation, and are required for successful mitosis [50,52].
When considering the cell biology of ADAMs, it may not be a co-incidence that SNXs and
NADPH complex organizer proteins (including Tks and NCF1) are the two predominant pro-
tein families that utilize a PX domain (phox domain) as their phosphoinositide-binding mem-
brane targeting module.
The functional role and significance of the SNX interactions by ADAMs are not known.
However, based on the established functions of SNXs in clathrin-dependent endocytosis and
intracellular protein sorting it is logical to assume that SNXs might regulate subcellular target-
ing and availability of ADAMs on the plasma membrane. Moreover, the capacity of the multi-
ple ADAM SH3-binding motifs to connect additional SH3-containing proteins with SNXs
suggest that beyond their sheddase activity ADAMs might have a general role as membrane an-
chored adaptor proteins in cellular signaling and trafficking. In support of this idea, such func-
tion has been described for ADAM12 in subcellular targeting of TGFβ-type II receptor after
TGFβ binding [53].
Like the SNXs, nephrocystin, another SH3-protein previously reported as an avid ADAM15
interacting protein [24,36], was identified as a dominant binding partner of ADAM12 in the
current study, and was also a frequently selected SH3 partner of ADAM19. In agreement, in
peptide array tests at least one peptide in ADAM12, ADAM15, and ADAM19, but not in other
ADAMs, gave an intense signal when probed with nephrocystin SH3 domain. The avidly bind-
ing peptides ADAM12 and ADAM15 contain the RxLPxxP sequence that we have previously
identified as a high affinity binding motif for nephrocystin SH3 [24], while ADAM19 carries a
related RxIPxxP motif.
In cells nephrocystin localizes to the base of the cilia [54], to focal adhesions, and to adher-
ence junctions [55]. Furthermore, it has been reported to interact with p130Cas, an important
Src substrate in transformed and migrating cells [55–57]. Mutations in nephrocystin cause the
most common form of childhood cystic kidney disease, nephronophthisis, by affecting ciliary
sorting/signaling and cell polarization [55]. Interestingly, ADAM12, a strong nephrocystin
binder, also selected the SH3 domain of another ciliary disease-associated protein AHI1/Jou-
berin [58]. Thus, understanding how the interactions of ADAM12/15 with nephrocystin and/
or AHI1 might be involved in regulation of cell polarization, adhesion, migration, or in out-
side-in signaling through these ADAMs seem like promising areas for further investigation.
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Until now, no SH3 interactions have been described for ADAM8. Remarkably, we found
that ADAM8 bound strongly and almost uniquely to two closely related proteins TOCA1 and
CIP4. Although the focus of this study was to comprehensively profile SH3 binding capacity
and preferences of the ADAM family, initial steps towards characterization of the cell biology
were taken in the case of ADAM8. In this regard we could show that binding of ADAM8 to
SNX33 and TOCA1 is not limited to our initial study systems involving isolated SH3 domains
and a cytosolic ADAM8 tail, but could be readily verified with corresponding full-length pro-
teins in human cells.
Like the SH3-PX-BAR subfamily of SNXs, TOCA1 and CIP4 contain a combination of an
SH3 domain and a membrane curvature sensing/inducing BAR domain, and they induce actin
polymerization associated with vesicle trafficking and protein sorting [59]. Many proteins with
a BAR or F-BAR domain also have an SH3 domains. Recently a potentially general autoinhibi-
tory mechanism controlling the membrane deforming activity of such proteins was described
for syndapin 1 [60]. This involves the release of an inactive clamped conformation by binding
the SH3 domain of syndapin 1 to external proline-rich ligands. Thus, it is reasonable to suggest
that CIP4 and TOCA1 are also regulated by a similar SH3-mediated autoinhibitory mecha-
nism, and that binding to ADAM8 would trigger their membrane remodeling activity.
Interestingly, ADAM8, TOCA1, and CIP4 are all associated with breast cancer metastasis
[61,62] and invadopodia formation. Thus, the interaction of ADAM8 with TOCA1, and/or
CIP4 could be worth a closer look as a potential mechanism driving breast cancer progression.
Further examples of previously unreported and highly ADAM-specific interactions identified
in this study include the binding of ADAM19 to the SH3 domains of Eps8L1 and Rim binding
protein 1 (RIMBP1; also known as PRAX-1). Both Eps8L1 and RIMBP1 serve complex, but so
far incompletely understood, roles as adaptor proteins in cellular signaling, making it premature
to propose detailed hypotheses regarding their possible contributions to ADAM19 biology.
Eps8L1 is a member of the Eps8-family of protein involved in regulation of actin remodeling
via small GTPases [63], and contains an SH3 domain with atypical binding preference towards
a PxxDY motif [64]. Indeed, such a motif is found in ADAM19, and bound strongly to Eps8L1
SH3 domain in our peptide array, albeit less strongly than CD3ε peptides (data not shown).
RIMBP1 is a multi-domain protein with three SH3 domains and FN type III repeats [65]. It
serves to couple Rab3-containing vesicles to voltage gated calcium channels in neuronal synap-
ses. ADAM19 is also expressed in neurons and regulates neuromuscular junction development
together with EphA4 [66] suggesting a possible connection to synaptic regulation along with
RIMBP1. Non-neural cells also express RIMBP1, which interacts with the peripheral benzodi-
azepine receptor and shows a cytoplasmic localization that includes vesicular structures [67].
ADAM19 predominantly localizes to Golgi membranes and to intracellular vesicles [68], sug-
gesting that these proteins could interact in cells.
Specific binding of the third SH3 domain of RIMBP1 (and RIMB2) to ADAM19 was de-
tected in our peptide array studies. The core SH3-binding region in ADAM19 contains several
proline and arginine residues but lacks a known SH3 binding motif, thus apparently harboring
yet another atypical SH3 target sequence.
The identification of several previously known ADAM-interacting proteins in our SH3 li-
brary screens provides good support for the relevance of the novel ADAM-binding partners
that we discovered. On the other hand, SH3 domains encoded by a number of previously re-
ported ADAM-associated proteins were not consistently or at all encountered in our phage dis-
play screens. Such missed SH3 domains include those of PACSIN2, PACSIN3, and endophilin
A1 (reported to bind to ADAMs 9, 10, 12, 13, 15, and 19, [21,49,69], Grb2 and Nck (reported
to bind to ADAM15, [27,70], Eve-1 (reported to bind to ADAMs 9, 10, 12, 15, and 17 [20]),
and SAP97 (reported to bind to ADAM10 [71].
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Of note, we failed to identify any SH3 domains that would be significantly selected from our
phage library by the major sheddases ADAM10 and ADAM17. As discussed above, Eve-1 has
been reported as a potential SH3-containing ligand for ADAM10 and ADAM17, whereas
ADAM10 has been reported to bind to the SH3 domains of SAP97 and Pacsin3.
The reasons why these SH3 domains were not identified as significant binding partners in
our ADAM screens are probably heterogeneous. Significant enrichment of a specific SH3 clone
from this phage library requires a threshold binding affinity that may be higher than what
weak but yet biologically relevant SH3-ligand complexes can provide. In their natural cellular
context such weak interactions may be stabilized by additional protein contacts, in some cases
provided by extra SH3 domains in the same protein. It is also important to note that using the
IUPred algorithm [72] all the ADAM-tails used in this study can be predicted to have a high
likelihood of being intrinsically disordered protein domains. It is therefore possible, if not like-
ly, that interactions with other proteins or plasma membrane lipids may induce novel confor-
mations in these tails (as proposed for ADAM10 by Deng et al [73]), and these in turn might
serve as attractive SH3 binding structures that are lacking in our bait proteins despite the fact
that they were expressed and purified from human 293T cells.
Moreover, as most ADAMs contain several potential SH3 binding sites, it is noteworthy
that instead of individual SH3 domains larger protein fragments or full-length multi-SH3 pro-
teins were used in most of these previous studies (Eve-1 has five, and Nck and Grb2 both two
SH3 domains). Thus, these interactions may depend on combinatorial binding of more than
one SH3 domain to the same ADAM tail. On the other hand, it should also be noted some of
the previously reported interactions may not be SH3-mediated. For example, SAP97 is a mem-
ber of the MAGUK family, where the SH3 domain is disjoint by pseudo-kinase domain, and
therefore unlikely to bind to proline-rich ligands like the ADAM10 tail [74].
It should also be noted that SH3 domains of some of these previously reported ADAM-part-
ners were in fact identified among the ADAM-selected clones that we sequenced, but at such a
low frequency that did not meet our criteria of significance. Specifically, SH3 domains of pac-
sins, endophilins, Grb2, and intersectins were occasionally encountered in our ADAM-screens.
However, given the nature of this phage library-based discovery system the relevance of such
infrequent hits cannot be ruled out.
Another laboratory [75] recently reported the identification of ADAM10-binding partners
using a commercially available version of our SH3 domain library. They used a bacterially ex-
pressed version of the intracellular ADAM10 tail as a bait, and reported it to bind as many as
38 different SH3 domains. However, analogously to our studies the overall phage enrichment
over negative control appeared to be low, and none of the individual SH3 domains were de-
tected at a high frequency (in fact most were observed only once). Nevertheless, it is interesting
to note that the most commonly encountered SH3 domain (2,7% of sequenced clones) was
endophilin-A2. Other SH3 domains that were detected more than twice among the 291 se-
quenced clones selected by GST-ADAM10 (but not GST) were the SFK family member Lck
and the palmitoyltransferase ZDHHC6. Our results provide support for these rare hits, as
ZDHHC6 and endophilin-A2 (or to be precise the highly homologous SH3 of the endophilin-
A2-related pseudogene SH3GL1P2) were repeatedly but infrequently (ZDHHC6 3% and
SH3GL1P2 2%) observed in our screens with ADAM10.
Considering that ADAM10 and 17 are central regulators of protein shedding, further stud-
ies to identify their relevant SH3 partners are clearly warranted. However, unlike many other
ADAMs, they do not show robust and specific affinity for towards any individual single SH3
domain. Therefore, functional rather than affinity-based approaches should be considered to
address this question.
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In summary, our current study provides a comprehensive survey of the SH3 partners of
ADAM sheddases, thereby confirming many previously reported interactions and revealing
several new ones. We found that the principal SH3 partners are typically shared by several
ADAMs, but also discovered robust ADAM-specific SH3 interactions. The highly shared inter-
action partners included Src-family kinases and adaptor proteins involved in regulation of
actin dynamics and ROS production. More specifically, a defining feature of ADAMs that
emerged from our studies was their ubiquitous binding to BAR and SH3 domain-containing
proteins associated in actin regulation, protein sorting, vesicle transport, and endocytosis. In
addition to two families of such proteins, namely SNXs and NADPH-organizers (which also
contain a PX domain) that dominated our interaction screens, a third class of BAR and
SH3-containing proteins, namely the PACSIN/endophilin family, has also been reported to
bind to ADAMs [21,49,69,75]. SH3 domains from this family were also encountered in our
screens, albeit at an inconclusively low frequency.
To generalize our findings, in comparison to other ADAMs, ADAM8 and ADAM9 ap-
peared to be the most dedicated to binding to SH3 domains of sorting proteins, whereas
ADAM12 is more specialized to interacting with signal transducing proteins. Selection of
TOCA1 and CIP4 as its preferred SH3 partners was a notable and specific property of
ADAM8. ADAM19 resembled ADAM12 in its SH3 binding profile, but bound to Tks5 and
SFKs less avidly, and was unique in its binding to the scaffolding protein RIMBP1. ADAM15
showed the broadest spectrum of binding to many different SH3 protein families. This can be
explained by the multiple ADAM15 isoforms generated via alternative mRNA splicing, which
have more unique and restricted SH3 binding potential [24].
Together our data provide an improved overall view of the protein interactomes recruited
by ADAMs via their multi SH3 binding site-containing intracellular tails. Detailed elucidation
of the cellular interactions that target and control the sheddase activity of ADAMs, and medi-
ate their effects on intracellular signaling and sorting processes is needed to better understand
and to therapeutically target the contribution of ADAMs to the pathogenesis of cancer and
other major diseases.
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